Striatal neurones have a specific ability to respond to phasic dopamine release

Journal of Physiology

Volumn 591, Issue 13, 2013, Pages 3197-3214

  Castro, Liliana R V ^a,b   Brito, Marina ^a,b,c   Guiot, Elvire ^a,b   Polito, Marina ^a,b   Korn, Christoph W ^a,b,f   Hervé, Denis ^b,d,e   Girault, Jean Antoine ^b,d,e   Paupardin Tritsch, Danièle ^a,b   Vincent, Pierre ^a,b  

^a CNRS   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c UNIVERSITY OF COIMBRA   (Portugal)

^d INSERM   (France)

^e INSTITUT DU FER À MOULIN   (France)

^f FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; DOPAMINE; DOPAMINE 1 RECEPTOR; PHOSPHODIESTERASE; PHOSPHODIESTERASE IV; PHOSPHOPROTEIN DARPP 32; PROTEIN C FOS; THREONINE; 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; DOPAMINE RECEPTOR STIMULATING AGENT; FORSKOLIN; ISOBUTYLMETHYLXANTHINE; PHOSPHODIESTERASE INHIBITOR; PPP1R1B PROTEIN, MOUSE;

ANATOMICAL VARIATION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIODEGRADATION; BIOSENSOR; BRAIN CELL; BRAIN SLICE; CELL FUNCTION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DOPAMINERGIC ACTIVITY; DOPAMINERGIC NERVE CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; INTRACELLULAR SIGNALING; MALE; MOUSE; NERVE STIMULATION; NEUROANATOMY; NEUROIMAGING; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; TARGET CELL; ANIMAL; C57BL MOUSE; GENETIC PROCEDURES; IN VITRO STUDY; METABOLISM; NERVE CELL; PHYSIOLOGY;

1-METHYL-3-ISOBUTYLXANTHINE; 2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; ANIMALS; BIOSENSING TECHNIQUES; COLFORSIN; CORPUS STRIATUM; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 4; DOPAMINE; DOPAMINE AGONISTS; DOPAMINE AND CAMP-REGULATED PHOSPHOPROTEIN 32; IN VITRO TECHNIQUES; MALE; MICE; MICE, INBRED C57BL; NEURONS; PHOSPHODIESTERASE INHIBITORS; PREFRONTAL CORTEX; PROTO-ONCOGENE PROTEINS C-FOS;

EID: 84879830984     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2013.252197     Document Type: Article

References (65)

1. Allen MD & Zhang J (2006). Subcellular dynamics of protein kinase A activity visualized by FRET-based reporters. Biochem Biophys Res Commun 348, 716-721.
2. Bateup HS, Svenningsson P, Kuroiwa M, Gong S, Nishi A, Heintz N & Greengard P (2008). Cell type-specific regulation of DARPP-32 phosphorylation by psychostimulant and antipsychotic drugs. Nat Neurosci 11, 932-939.
3. olf are anosmic. Neuron 20, 69-81.
4. 2 receptor-expressing striatal neurons in response to cocaine and haloperidol. J Neurosci 28, 5671-5685.
5. Börner S, Schwede F, Schlipp A, Berisha F, Calebiro D, Lohse MJ & Nikolaev VO (2011). FRET measurements of intracellular cAMP concentrations and cAMP analog permeability in intact cells. Nat Protoc 6, 427-438.
6. 2 subtypes of dopamine receptors in rat brain. J Neurosci 6, 3177-3188.
7. Bromberg-Martin ES, Matsumoto M & Hikosaka O (2010). Dopamine in motivational control: rewarding, aversive, and alerting. Neuron 68, 815-834.
8. Calebiro D, Nikolaev VO, Gagliani MC, de Filippis T, Dees C, Tacchetti C, Persani L & Lohse MJ (2009). Persistent cAMP-signals triggered by internalized G-protein-coupled receptors. PLoS Biol 7, e1000172.
9. Castro LR, Gervasi N, Guiot E, Cavellini L, Nikolaev VO, Paupardin-Tritsch D & Vincent P (2010). Type 4 phosphodiesterase plays different integrating roles in different cellular domains in pyramidal cortical neurons. J Neurosci 30, 6143-6151.
10. Cherry JA & Davis RL (1999). Cyclic AMP phosphodiesterases are localized in regions of the mouse brain associated with reinforcement, movement, and affect. J Comp Neurol 407, 287-301.
11. Conti M & Beavo J (2007). Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling. Annu Rev Biochem 76, 481-511.
12. olf is necessary for coupling D1 and A2a receptors to adenylyl cyclase in the striatum. J Neurochem 76, 1585-1588.
13. Corvol JC, Valjent E, Pascoli V, Robin A, Stipanovich A, Luedtke RR, Belluscio L, Girault JA & Herve D (2007). Quantitative changes in Gαolf protein levels, but not D1 receptor, alter specifically acute responses to psychostimulants. Neuropsychopharmacology 32, 1109-1121.
14. Dearry A, Gingrich JA, Falardeau P, Fremeau RTJ, Bates MD & Caron MG (1990). Molecular cloning and expression of the gene for a human D1 dopamine receptor. Nature 347, 72-76.
15. Ducros M, Moreaux L, Bradley J, Tiret P, Griesbeck O & Charpak S (2009). Spectral unmixing: analysis of performance in the olfactory bulb in vivo. PLoS One 4, e4418.
16. Dunn TA & Feller MB (2008). Imaging second messenger dynamics in developing neural circuits. Dev Neurobiol 68, 835-844.
17. Dunn TA, Wang CT, Colicos MA, Zaccolo M, DiPilato LM, Zhang J, Tsien RY & Feller MB (2006). Imaging of cAMP levels and protein kinase A activity reveals that retinal waves drive oscillations in second-messenger cascades. J Neurosci 26, 12807-12815.
18. Ehrengruber MU, Lundstrom K, Schweitzer C, Heuss C, Schlesinger S & Gähwiler BH (1999). Recombinant Semliki Forest virus and Sindbis virus efficiently infect neurons in hippocampal slice cultures. Proc Natl Acad Sci U S A 96, 7041-7046.
19. Fremeau RTJ, Duncan GE, Fornaretto MG, Dearry A, Gingrich JA, Breese GR & Caron MG (1991). Localization of D1 dopamine receptor mRNA in brain supports a role in cognitive, affective, and neuroendocrine aspects of dopaminergic neurotransmission. Proc Natl Acad Sci U S A 88, 3772-3776.
20. Garris PA & Wightman RM (1994). Different kinetics govern dopaminergic transmission in the amygdala, prefrontal cortex, and striatum: an in vivo voltammetric study. J Neurosci 14, 442-450.
21. 3H]forskolin binding sites in the rat brain using quantitative autoradiography. Eur J Pharmacol 106, 223-225.
22. Gervasi N, Hepp R, Tricoire L, Zhang J, Lambolez B, Paupardin-Tritsch D & Vincent P (2007). Dynamics of protein kinase A signaling at the membrane, in the cytosol, and in the nucleus of neurons in mouse brain slices. J Neurosci 27, 2744-2750.
23. Gonon F (1997). Prolonged and extrasynaptic excitatory action of dopamine mediated by D1 receptors in the rat striatum in vivo. J Neurosci 17, 5972-5978.
24. 2+ spikes. Nature 418, 93-96.
25. Grace AA & Bunney BS (1980). Nigral dopamine neurons: intracellular recording and identification with L-dopa injection and histofluorescence. Science 210, 654-656.
26. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260, 3440-3450.
27. Henny P, Brown MT, Northrop A, Faunes M, Ungless MA, Magill PJ & Bolam JP (2012). Structural correlates of heterogeneous in vivo activity of midbrain dopaminergic neurons. Nat Neurosci 15, 613-619.
28. Hepp R, Tricoire L, Hu E, Gervasi N, Paupardin-Tritsch D, Lambolez B & Vincent P (2007). Phosphodiesterase type 2 and the homeostasis of cyclic GMP in living thalamic neurons. J Neurochem 102, 1875-1886.
29. Hervé D & Girault J-A (2005). Signal transduction of dopamine receptors. In Dopamine, ed. Dunnett SB, Bentivoglio M & Björklund A, pp. 109-151. Elsevier.
30. Houslay MD (2010). Underpinning compartmentalised cAMP signalling through targeted cAMP breakdown. Trends Biochem Sci 35, 91-100.
31. Hu E, Demmou L, Cauli B, Gallopin T, Geoffroy H, Harris-Warrick RM, Paupardin-Tritsch D, Lambolez B, Vincent P & Hepp R (2011). VIP, CRF, and PACAP act at distinct receptors to elicit different cAMP/PKA dynamics in the neocortex. Cereb Cortex 21, 708-718.
32. Kuroiwa M, Snyder GL, Shuto T, Fukuda A, Yanagawa Y, Benavides DR, Nairn AC, Bibb JA, Greengard P & Nishi A (2012). Phosphodiesterase 4 inhibition enhances the dopamine D1 receptor/PKA/DARPP-32 signaling cascade in frontal cortex. Psychopharmacology (Berl) 219, 1065-1079.
33. Lammel S, Ion DI, Roeper J & Malenka RC (2011). Projection-specific modulation of dopamine neuron synapses by aversive and rewarding stimuli. Neuron 70, 855-862.
34. 2+ and cAMP signaling in the insulin-secreting MIN6 β-cell line. J Biol Chem 280, 31294-31302.
35. Lane-Ladd SB, Pineda J, Boundy VA, Pfeuffer T, Krupinski J, Aghajanian GK & Nestler EJ (1997). CREB (cAMP response element-binding protein) in the locus coeruleus: biochemical, physiological, and behavioral evidence for a role in opiate dependence. J Neurosci 17, 7890-7901.
36. 2+ channel regulation in adult rat ventricular myocytes: role of phosphodiesterases. Circ Res 102, 1091-1100.
37. Matsuoka I, Suzuki Y, Defer N, Nakanishi H & Hanoune J (1997). Differential expression of type I, II, and V adenylyl cyclase gene in the postnatal developing rat brain. J Neurochem 68, 498-506.
38. Monsma FJJ, Mahan LC, McVittie LD, Gerfen CR & Sibley DR (1990). Molecular cloning and expression of a D1 dopamine receptor linked to adenylyl cyclase activation. Proc Natl Acad Sci U S A 87, 6723-6727.
39. Neves SR, Tsokas P, Sarkar A, Grace EA, Rangamani P, Taubenfeld SM, Alberini CM, Schaff JC, Blitzer RD, Moraru II & Iyengar R (2008). Cell shape and negative links in regulatory motifs together control spatial information flow in signaling networks. Cell 133, 666-680.
40. Nguyen QT, Tsai PS & Kleinfeld D (2006). MPScope: a versatile software suite for multiphoton microscopy. J Neurosci Methods 156, 351-359.
41. Nicol X, Hong KP & Spitzer NC (2011). Spatial and temporal second messenger codes for growth cone turning. Proc Natl Acad Sci U S A 108, 13776-13781.
42. Nikolaev VO, Bunemann M, Hein L, Hannawacker A & Lohse MJ (2004). Novel single chain cAMP sensors for receptor-induced signal propagation. J Biol Chem 279, 37215-37218.
43. Nishi A, Kuroiwa M, Miller DB, O'Callaghan JP, Bateup HS, Shuto T, Sotogaku N, Fukuda T, Heintz N, Greengard P & Snyder GL (2008). Distinct roles of PDE4 and PDE10A in the regulation of cAMP/PKA signaling in the striatum. J Neurosci 28, 10460-10471.
44. Norris RP, Ratzan WJ, Freudzon M, Mehlmann LM, Krall J, Movsesian MA, Wang H, Ke H, Nikolaev VO & Jaffe LA (2009). Cyclic GMP from the surrounding somatic cells regulates cyclic AMP and meiosis in the mouse oocyte. Development 136, 1869-1878.
45. O'Donnell JM & Zhang HT (2004). Antidepressant effects of inhibitors of cAMP phosphodiesterase (PDE4). Trends Pharmacol Sci 25, 158-163.
46. 3H]rolipram binding autoradiography. Comparison with monkey and rat brain. J Chem Neuroanat 20, 349-374.
47. Polli JW & Kincaid RL (1994). Expression of a calmodulin-dependent phosphodiesterase isoform (PDE1B1) correlates with brain regions having extensive dopaminergic innervation. J Neurosci 14, 1251-1261.
48. Ramos BP, Birnbaum SG, Lindenmayer I, Newton SS, Duman RS & Arnsten AF (2003). Dysregulation of protein kinase A signaling in the aged prefrontal cortex: new strategy for treating age-related cognitive decline. Neuron 40, 835-845.
49. Schultz W (1998). Predictive reward signal of dopamine neurons. J Neurophysiol 80, 1-27.
50. Schultz W & Dickinson A (2000). Neuronal coding of prediction errors. Annu Rev Neurosci 23, 473-500.
51. Seeger TF, Bartlett B, Coskran TM, Culp JS, James LC, Krull DL, Lanfear J, Ryan AM, Schmidt CJ, Strick CA, Varghese AH, Williams RD, Wylie PG & Menniti FS (2003). Immunohistochemical localization of PDE10A in the rat brain. Brain Res 985, 113-126.
52. Shelly M, Lim BK, Cancedda L, Heilshorn SC, Gao H & Poo MM (2010). Local and long-range reciprocal regulation of cAMP and cGMP in axon/dendrite formation. Science 327, 547-552.
53. Sunahara RK, Niznik HB, Weiner DM, Stormann TM, Brann MR, Kennedy JL, Gelernter JE, Rozmahel R, Yang YL, Israel Y, Seeman P & O'Dowd BF (1990). Human dopamine D1 receptor encoded by an intronless gene on chromosome 5. Nature 347, 80-83.
54. Svenningsson P, Nishi A, Fisone G, Girault JA, Nairn AC & Greengard P (2004). DARPP-32: an integrator of neurotransmission. Annu Rev Pharmacol Toxicol 44, 269-296.
55. Svenningsson P, Tzavara ET, Carruthers R, Rachleff I, Wattler S, Nehls M, McKinzie DL, Fienberg AA, Nomikos GG & Greengard P (2003). Diverse psychotomimetics act through a common signaling pathway. Science 302, 1412-1415.
56. Tsai HC, Zhang F, Adamantidis A, Stuber GD, Bonci A, de Lecea L & Deisseroth K (2009). Phasic firing in dopaminergic neurons is sufficient for behavioral conditioning. Science 324, 1080-1084.
57. van der Krogt GN, Ogink J, Ponsioen B & Jalink K (2008). A comparison of donor-acceptor pairs for genetically encoded FRET sensors: application to the Epac cAMP sensor as an example. PLoS One 3, e1916.
58. Van Staveren WC, Steinbusch HW, Markerink-Van Ittersum M, Repaske DR, Goy MF, Kotera J, Omori K, Beavo JA & De Vente J (2003). mRNA expression patterns of the cGMP-hydrolyzing phosphodiesterases types 2, 5, and 9 during development of the rat brain. J Comp Neurol 467, 566-580.
59. Vincent P, Castro LR, Gervasi N, Guiot E, Brito M & Paupardin-Tritsch D (2012). PDE4 control on cAMP/PKA compartmentation revealed by biosensor imaging in neurons. Horm Metab Res 44, 786-789.
60. 2-adrenergic receptor signaling and desensitization elucidated by quantitative modeling of real time cAMP dynamics. J Biol Chem 283, 2949-2961.
61. Yamashita N, Yamauchi M, Baba J & Sawa A (1997). Phosphodiesterase type 4 that regulates cAMP level in cortical neurons shows high sensitivity to rolipram. Eur J Pharmacol 337, 95-102.
62. Yger M & Girault JA (2011). DARPP-32, Jack of All Trades. Master of Which Front Behav Neurosci 5, 56.
63. Zhang HT, Huang Y, Jin SL, Frith SA, Suvarna N, Conti M & O'Donnell JM (2002a). Antidepressant-like profile and reduced sensitivity to rolipram in mice deficient in the PDE4D phosphodiesterase enzyme. Neuropsychopharmacology 27, 587-595.
64. Zhang J, Campbell RE, Ting AY & Tsien RY (2002b). Creating new fluorescent probes for cell biology. Nat Rev Mol Cell Biol 3, 906-918.
65. 1 dopamine receptors. Nature 347, 76-80.